Commercialization of Medical Care Residences and Upfront Investment Costs
First written in FY2026-H1. 3 of 6 entries say "Mitigated", first in 2026-06-25. Latest entry: 2026-07-30.
1 other company's latest entry also says "Mitigated".
- FY2026WorsenedAnnual report
「With the aim of increasing occupancy and unit prices over the long term, we made active upfront investments in recruitment and training, resulting in a segment loss of ¥262 million, compared with segment profit of ¥299 million in the previous consolidated fiscal year.」
The medical care residence business swung from profit in the previous year to a ¥262 million loss as a result of upfront investment to improve occupancy and unit prices. - 2026-06-04AdvancedGeneral Meetings of Shareholders
「As a result of actively making upfront investments in hiring and training personnel to improve occupancy and charges over the long term, the segment loss was ¥262 million, compared with segment profit of ¥299 million in the previous consolidated fiscal year, while EBITDA was ¥1,349 million, compared with ¥640 million in the previous consolidated fiscal year.」
メディカルケアレジデンスで売上収益が7,704百万円に拡大し、稼働率・単価向上を目的とする先行投資の結果、セグメント損失262百万円が発生した実績を示している。 - FY2026-H1First statedAnnual report
「While sales of the medication support system “服やっくん” continued to grow steadily and revenue from medical fees related to home-visit nursing increased, revenue was ¥3,797 million owing to restrictions on admissions during renovations at 3 facilities owned by ノアコンツェル to convert them into hospice floors. Segment loss was ¥96 million and EBITDA was ¥681 million, as upfront investment costs were incurred for hiring care workers and nurses and improving occupancy and unit prices.」
The newly established medical care residence segment generated revenue of ¥3,797 million, but recorded a ¥96 million segment loss due to restricted admissions during renovations and upfront investment in recruitment and other measures.